© 2022 MJH Life Sciences and Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ , Pharmacy Times – Pharmacy Practice News and Expert Insights. All rights reserved.
September 05, 2019
On November 2018, the FDA approved Pfizer’s glasdegib (Daurismo) for the treatment of newly diagnosed acute myeloid leukemia (AML) in patients 75 years and older with comorbidities that prevent the use of intensive induction-dose chemotherapy.
July 16, 2019
Mergers and acquisitions among health care giants are causing massive disruption in specialty pharmacy.
May 29, 2019
The importance of improving the specialty pharmacy experience for patients newly diagnosed with a life-changing disease.
April 23, 2019
The potential for prescription drugs to cost more than $1 million for a treatment regimen creates a mixed bag of conundrums for the health care system.
April 15, 2019
Each member of the specialty pharmacy care team is an essential component in influencing and ensuring positive outcomes of therapy.
April 04, 2019
Specialty pharmacy can benefit from having definitive a center of excellence model that caters to respective therapies and disease states.